Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%,… read more.
Article written by Bruce Sylvester. Researchers report that, when compared with dual inhaler therapy for moderate to severe asthma, triple therapy for children aged 6 to 18 years… read more.
Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents,… read more.
Article by Bruce Sylvester. Vaping by teens and adults appears to be related to an increase in the likelihood of developing asthma and experiencing asthma attacks, researchers reported… read more.
Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%,… read more.
Wheezing, coughing that doesn’t stop, a pale and sweaty face: clinically, severe asthma attacks look very similar from patient to patient.
Article written by Bruce Sylvester Pediatric proton pump inhibitor (PPI) treatment appears to be related to an increased risk of asthma in children, researchers reported on Feb. 8…. read more.
The European Commission has approved a marketing authorisation for triple combination Trimbow (beclometasone + formoterol + glycopyrronium) from Chiesi, for patiemts with asthma therapy.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
